enGene to Participate in Upcoming Investor Conferences
enGene Holdings Inc. (ENGN)
Company Research
Source: Business Wire
BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN or “enGene”), a clinical-stage, non-viral genetic medicines company, today announced that management will participate in the following investor conferences:Oppenheimer 36th Annual Healthcare Life Sciences ConferenceDate: Thursday, February 26, 2026Format: PresentationTime: 1:20 p.m. ETLeerink Partners 2026 Global Healthcare ConferenceDate: Monday, March 9, 2026Format: Fireside chatTime: 8:00 a.m. ETBarclays 28th Annual Global Healthcare ConferenceDate: Tuesday, March 10, 2026Format: Fireside chatTime: 9:00 a.m. ETCitizens Life Sciences ConferenceDate: Wednesday, March 11, 2026Format: Fireside chatTime: 1:40 p.m. ETA live webcast of these events can be accessed on the "Events and Presentations” page under the “Investors” section of the enGene website at www.engene.com and will be archived there for 90 days.About enGeneenGene is a clinical-stage biotechnology company mainstreaming genetic medicines through the de
Show less
Read more
Impact Snapshot
Event Time:
ENGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ENGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ENGN alerts
High impacting enGene Holdings Inc. news events
Weekly update
A roundup of the hottest topics
ENGN
News
- enGene Maps BLA by End-2026, Targets 2027 Launch for Lead NMIBC Therapy at Oppenheimer Conference [Yahoo! Finance]Yahoo! Finance
- Jefferies Sets a $28 PT for enGene Holdings Inc. (ENGN) [Yahoo! Finance]Yahoo! Finance
- enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026Business Wire
- Both private equity firms who control a good portion of enGene Holdings Inc. (NASDAQ:ENGN) along with institutions must be dismayed after last week's 16% decrease [Yahoo! Finance]Yahoo! Finance
- enGene (NASDAQ:ENGN) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $28.00 price target on the stock.MarketBeat
ENGN
Sec Filings
- 3/3/26 - Form EFFECT
- 2/19/26 - Form S-3
- 2/19/26 - Form 10-K/A
- ENGN's page on the SEC website